1. Can Pediatric Heart Failure Therapy Be Improved? Yes It Can, But…

   • Dietmar Schranz

   Current Opinion Open access 06 August 2022 Pages: 567 - 571

   

2. Mechanism-Based Pharmacological Treatment for Chronic Non-cancer Pain in Adolescents: Current Approaches and Future Directions

   • Alice Bruneau
   • Sabrina Carrié
   • Pablo Ingelmo

   Leading Article 02 September 2022 Pages: 573 - 583

   

3. Pharmacotherapy for Spinal Muscular Atrophy in Babies and Children: A Review of Approved and Experimental Therapies

   • Claudia A. Chiriboga

   Review Article 27 August 2022 Pages: 585 - 602

   

4. Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years

   • Victoria C. Ziesenitz
   • Tatjana Welzel
   • Johannes N. van den Anker

   Review Article Open access 02 September 2022 Pages: 603 - 655

5. Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small Patients

   • Robert A. Beckman
   • Zoran Antonijevic
   • Rui Tang

   Review Article 15 October 2022 Pages: 657 - 669

   

6. Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study

   • Maddalena Napolitano
   • Gabriella Fabbrocini
   • Cataldo Patruno

   Original Research Article 27 August 2022 Pages: 671 - 678

   

7. New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products

   • Ann-Katrine Birkelund Mogensen
   • Helle Christiansen
   • Christine Erikstrup Hallgreen

   Original Research Article 13 August 2022 Pages: 679 - 687

   

8. High-Concentration Intravenous Immunoglobulin May Influence the Course of Fever and Rate of Reported Treatment Resistance in Children With Kawasaki Disease: A Single-Center Retrospective Analysis

   • Seung Beom Han
   • Woosuck Suh
   • Jung-Woo Rhim

   Original Research Article 26 September 2022 Pages: 689 - 697

   

9. Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations

   • Jocelyn H. Leu
   • Natalie J. Shiff
   • Zhenhua Xu

   Original Research Article Open access 28 September 2022 Pages: 699 - 714

   

10. Phentermine/Topiramate: Pediatric First Approval

    • Sohita Dhillon

    AdisInsight Report 05 September 2022 Pages: 715 - 720